Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Secretary Raimondo Announces $153 Million to Promote Innovation in Biopharmaceutical Manufacturing

$83 million in funding comes from the American Rescue Plan to support research and development to prevent, prepare for and respond to coronavirus outbreaks.

Two people in coveralls and hair covers check the readouts on laboratory equipment.

Researchers work in the fermentation lab at the Biomanufacturing Training and Education Center at North Carolina State University.

Credit: NIIMBL/BTEC @ North Carolina State University

WASHINGTON — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C. 

NIIMBL is a public-private partnership designed to accelerate innovation in the U.S. biopharmaceutical industry, which produces vaccines, monoclonal antibodies, gene therapies and other medical products derived from biological sources. NIIMBL is a Manufacturing USA® institute sponsored by the Department of Commerce.

Commerce Secretary Gina Raimondo Announces $153M for Innovation in Biopharmaceutical Manufacturing
Commerce Secretary Gina Raimondo Announces $153M for Innovation in Biopharmaceutical Manufacturing
Commerce Secretary Announces $153M for Innovation in Biopharmaceutical Manufacturing

Read the full news release on the Department of Commerce website.

Released July 14, 2021, Updated August 3, 2021